Naviter Wealth LLC Makes New Investment in Haleon PLC Sponsored ADR $HLN

Naviter Wealth LLC bought a new position in Haleon PLC Sponsored ADR (NYSE:HLN) in the second quarter, according to the company in its most recent disclosure with the SEC. The fund bought 46,014 shares of the company’s stock, valued at approximately $477,000.

A number of other large investors have also added to or reduced their stakes in the stock. Farther Finance Advisors LLC grew its position in Haleon by 8.8% in the 1st quarter. Farther Finance Advisors LLC now owns 12,861 shares of the company’s stock worth $131,000 after purchasing an additional 1,041 shares during the period. Apollon Wealth Management LLC grew its position in Haleon by 5.4% in the 1st quarter. Apollon Wealth Management LLC now owns 21,722 shares of the company’s stock worth $224,000 after purchasing an additional 1,111 shares during the period. Holistic Financial Partners grew its position in Haleon by 9.6% in the 1st quarter. Holistic Financial Partners now owns 13,379 shares of the company’s stock worth $138,000 after purchasing an additional 1,172 shares during the period. AE Wealth Management LLC grew its position in Haleon by 6.5% in the 1st quarter. AE Wealth Management LLC now owns 19,323 shares of the company’s stock worth $199,000 after purchasing an additional 1,186 shares during the period. Finally, Allspring Global Investments Holdings LLC grew its position in Haleon by 4.0% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 31,423 shares of the company’s stock worth $321,000 after purchasing an additional 1,200 shares during the period. Institutional investors own 6.67% of the company’s stock.

Haleon Trading Up 1.2%

Shares of Haleon stock opened at $9.19 on Wednesday. The company’s fifty day simple moving average is $9.41 and its 200-day simple moving average is $10.01. The stock has a market capitalization of $40.90 billion, a PE ratio of 23.55, a P/E/G ratio of 2.65 and a beta of 0.20. Haleon PLC Sponsored ADR has a 1-year low of $8.71 and a 1-year high of $11.42. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.87 and a quick ratio of 0.63.

Haleon Increases Dividend

The firm also recently declared a semi-annual dividend, which was paid on Thursday, September 18th. Shareholders of record on Friday, August 15th were paid a $0.0555 dividend. This represents a yield of 190.0%. The ex-dividend date was Friday, August 15th. This is a boost from Haleon’s previous semi-annual dividend of $0.05. Haleon’s dividend payout ratio (DPR) is currently 28.21%.

Wall Street Analysts Forecast Growth

A number of research firms have commented on HLN. Wall Street Zen downgraded shares of Haleon from a “buy” rating to a “hold” rating in a research report on Saturday, July 12th. Barclays cut shares of Haleon from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, September 16th. Weiss Ratings reiterated a “hold (c)” rating on shares of Haleon in a research note on Wednesday, October 8th. Finally, The Goldman Sachs Group upgraded shares of Haleon from a “neutral” rating to a “buy” rating in a research note on Wednesday, September 10th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Haleon currently has a consensus rating of “Moderate Buy” and a consensus target price of $12.33.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.